Whitehawk Therapeutics WHWK Cash Flow Statement (2010-2026)

NASDAQ WHWK
$3.29 +0.10 (+2.98%)
At close: Oct 21, 2026 · 4:00 PM EDT
Reported Financials

Whitehawk Therapeutics Quarterly Cash Flow Statement

Periods 64 quarters
Latest Jun 2026

Whitehawk Therapeutics reported cash from operations of -$14.53M and free cash flow of -$14.53M for the quarter ended Jun 2026, up 72.6% year over year. This cash flow statement covers 64 quarters of results from Sep 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-87.09M-16.00M-13.86M-18.27M-14.50M-13.91M-15.22M-17.97M-16.30M-16.27M-18.29M-14.58M-12.55M-18.27M73.02M-52.62M-17.75M-23.30M-22.19M-16.64M
Depreciation and DepletionDep. & Depletion
0.04M0.04M0.04M0.08M0.05M0.05M0.05M0.05M0.06M0.02M0.01M0.00M0.00M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
-0.15M-1.07M-1.20M-0.86M-0.59M-0.49M
Depreciation & Amortization (CF)Dep. & Amort.
0.03M0.07M0.07M0.03M0.01M0.05M0.04M0.04M0.04M0.04M0.05M0.05M0.05M0.05M0.06M0.02M0.01M0.00M0.00M
Share-based CompensationStock Comp.
0.65M1.38M1.78M2.24M2.76M2.87M2.74M3.05M3.05M3.11M3.59M2.84M2.56M1.85M1.68M3.09M2.72M2.39M2.19M1.52M
Gains from Sales and DivestituresGains Divest
87.44M-0.18M
Asset Writedowns and ImpairmentWritedown
74.16M
Other non-cash itemsOther Non-Cash
0.43M0.17M0.17M0.11M0.11M0.11M0.29M0.12M0.12M0.23M0.29M0.12M0.12M-0.27M0.07M0.03M0.03M-0.14M0.01M0.04M
Change in Working Capital
Change in ReceivablesChange Receivables
2.71M-0.65M0.20M-0.40M3.70M-1.89M2.04M-0.23M-0.56M0.99M0.62M-0.64M1.00M
Change in InventoryChange Inventory
0.20M0.53M0.01M1.13M1.94M-0.58M-0.32M2.23M-0.49M0.16M-0.63M-0.16M-0.17M
Change in Account PayablesChange Payables
0.16M
Change in Accured ExpensesChange Accured Exp.
3.64M3.43M-4.13M1.02M5.03M1.30M-1.54M-5.13M1.72M4.82M-6.76M2.50M-6.10M0.59M0.98M-2.71M0.99M4.67M-3.49M0.03M
Change in Other Operating AssetsOther Assets Change
-0.02M1.59M0.45M-0.21M0.97M-0.19M0.53M-1.65M-1.85M-1.15M-1.09M-1.59M-0.29M-0.36M-0.88M0.74M0.80M0.21M-1.63M-0.92M
Change in Other Operating LiabilitiesOther Liabilities Change
-8.57M0.15M-0.04M0.06M-0.19M-0.12M-0.12M-0.13M-0.13M-0.13M-0.13M-0.13M0.27M-0.32M-0.29M
Other Working Capital ChangesOther WC Changes
-8.55M-1.44M-0.50M0.28M-1.16M0.07M-0.65M1.52M1.73M1.02M0.97M1.46M0.56M0.04M0.59M-0.74M-0.80M-0.21M1.63M0.92M
Cash from OperationsCash from Ops.
-17.37M-12.43M-19.42M-10.72M-8.20M-11.31M-21.31M-16.76M-11.95M-9.64M-19.65M-9.16M-15.69M-15.05M-11.86M-52.96M-15.38M-17.23M-22.21M-14.53M
Investing Activities
Capital ExpendituresCapex
0.05M0.02M0.24M0.10M0.08M1.37M0.69M1.10M0.82M0.74M0.54M0.19M0.19M0.55M0.00M
Change in Property, Plant and EquipmentChange in PP&E
-0.05M-0.02M-0.24M-0.10M-0.08M-1.37M-0.69M-1.10M-0.82M-0.74M-0.54M-0.19M-0.19M-0.55M0.00M
Divestments
101.36M-0.07M
Net of Acquisitions & DivestmentsNet Acquisitions
101.36M-0.07M
Purchase of InvestmentsInvestments Purchased
48.14M97.05M23.05M27.49M13.90M7.65M18.91M9.93M0.00M32.22M93.56M22.92M19.19M50.64M
Sale and Maturity of InvestmentsInvestments Sold
12.75M40.75M51.25M41.26M18.36M18.94M15.88M15.20M13.32M14.69M3.39M2.00M39.76M38.62M33.77M
Cash from Investing ActivitiesCash from Investing
25.36M-0.05M-0.02M-0.24M-48.24M-84.38M16.33M50.56M12.67M3.65M10.56M-3.57M5.09M13.13M115.50M-28.83M-91.63M16.85M19.43M-16.87M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
Non-Current Debt
Net Debt Issuances and RepaymentsNet Debt Issuance
Change in Capital Stock
Common Stock IssuedStock Issued
300.40M0.09M0.30M0.14M72.52M0.33M0.01M0.36M0.00M0.11M0.09M0.05M100.02M0.03M0.03M87.58M
Net Shares Issued and RepurchasedNet Shares Issued
300.40M0.09M0.30M0.14M72.52M0.33M0.01M0.36M0.00M0.11M0.09M0.05M100.02M0.03M0.03M87.58M
Net Equity Issued and RepurchasedNet Equity Issued
300.40M0.09M0.30M0.14M72.52M0.33M0.01M0.36M0.00M0.11M0.09M0.05M100.02M0.03M0.03M87.58M
Other financing activitiesOther financing
-9.62M-0.44M-0.05M-0.08M-0.03M-0.01M-0.01M0.00M-4.82M-0.88M-5.74M
Cash from Financing ActivitiesCash from Financing
141.72M0.09M0.30M-0.09M72.52M-0.11M0.01M0.31M-0.08M0.08M-0.01M0.09M0.05M95.20M-0.85M0.03M81.84M
Additional items
Change in Cash
149.70M-12.39M-19.14M-11.05M16.08M-95.80M-4.97M34.12M0.64M-5.92M-9.11M-12.64M-10.60M-1.87M198.84M-82.63M-107.01M-0.36M-2.78M50.44M
Ending Cash Balance
161.38M148.99M129.85M118.80M134.88M39.08M34.11M68.23M68.87M62.95M53.84M41.20M30.60M28.73M227.57M144.94M37.57M34.79M85.23M
Free Cash FlowFCF
-17.37M-12.47M-19.44M-10.96M-8.30M-11.39M-22.68M-17.45M-13.05M-10.46M-20.39M-9.70M-15.88M-15.24M-12.42M-52.96M-15.38M-17.23M-22.21M-14.53M
Net Cash FlowNCF
149.70M-12.39M-19.14M-11.05M16.08M-95.80M-4.97M34.12M0.64M-5.92M-9.11M-12.64M-10.60M-1.87M198.84M-82.63M-107.01M-0.36M-2.78M50.44M
Interest Paid
0.02M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.04M

Whitehawk Therapeutics Cash Flow Statement API

Pull Whitehawk Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=WHWK&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY